Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

HIV/AIDS Advocacy Group Calls For Condom Use In Los Angeles County Adult Film Industry; County Response To HIV Cases Questioned
The AIDS Healthcare Foundation (AHF) on Thursday called on Los Angeles County health officials to require that condoms be used in the adult film industry or shut down production in light of a recent report that a number of people at the Adult Industry Medical Healthcare Foundation (AIMHF) clinic have tested positive for HIV since 2004, the Los Angeles Times reports. The group also criticized the county"s response to cases of HIV in the adult industry. Michael Weinstein, president of AHF, said, "L.A. County public health officials have been asleep at the switch with regard to monitoring HIV and STD prevention and testing in the region"s porn industry." Other questions have been raised regarding the county"s role in the notification of partners of those who test positive for HIV, according to the Times (Los Angeles Times, 6/19).

Pregnancy Rates Unaffected By Single Thawed Embryo Transfer After PGD
Transferring just one embryo at a time to a woman"s womb after embryos have undergone preimplantation genetic diagnosis (PGD) and freezing at the blastocyst stage has become a real option after researchers achieved pregnancy rates that were as good as those for blastocysts that had not had a cell removed for PGD before freezing. Their results mean that it will be possible to reduce the number of multiple pregnancies after PGD and the consequent complications associated with these pregnancies.
News of the day
Eisai And Pfizer Decide Not To Appeal NICE Decision And Call For An Expedited Review Of Guidance For Alzheimer's Disease
On June 11, the National Institute for Health and Clinical Excellence
Nutrition

BioElectronics Announces Pivotal Clinical Study On Musculoskeletal Disorders

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced its sponsorship of a groundbreaking clinical study on musculoskeletal disorders. The randomized, double blinded and placebo-controlled study will be supervised by a primary investigator, Sheena Kong, MD of San Francisco, California in conjunction with several other leading physicians. "This is a very exciting field of research and we are looking forward to determining the safety and efficacy of BioElectronics Corporation"s ActiPatch for the treatment of many different types of musculoskeletal complaints," commented Dr. Kong. "Since my days studying at Harvard University I have been very interested in treatments such as Pulsed Electromagnetic Field therapy (PEMF) as an alternative to pharmaceuticals. We are currently in process of working with our Independent Review Board (IRB) and registering the study with the National Institutes of Health (NIH). Patient recruitment is expected to begin over the next few weeks. We believe this will be one of the largest studies ever completed on the subject of general muscular skeletal complaints." Andrew Whelan, CEO of BioElectronics Corp., added, "The sponsorship and completion of the study are significant events for our Company. While we are seeing success within the plastic surgery market and in our international distribution channels, we believe the U.S. markets for back, knee, foot/ankle, and elbow pain are our biggest opportunities. This study is specifically designed to allow us to apply to the U.S. Food and Drug Administration for an indication for pain relief for general muscular skeletal complaints. With the many concerns over the dangers of taking medications such as acetaminophen and NSAIDs, we believe U.S. consumers are looking for safer and more effective pain relief options. We believe our unique and patented drug-free technologies will effectively fill this need." The management team of BioElectronics will hold a conference call on Thursday, June 18 at 4:15 p.m. (EDT) to discuss this study and other ongoing clinical trials several of which are nearing conclusion. On the call Barry Eppley, M.D., D.M.D will discuss the recent clinical study on dysmenorrhea and Sheena Kong, MD will discuss the design of the musculoskeletal disorder study. To access the conference call, please dial 712-432-0080 approximately 10 minutes prior to the start time and enter access code 404367# to be placed into the conference. BioElectronics Corporation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009